Stemedica Cell Technologies, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2005-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.stemedica.com
A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19
- Conditions
- Covid19
- Interventions
- Biological: hMSC
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2022-07-08
- Lead Sponsor
- Stemedica Cell Technologies, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04780685
- Locations
- 🇺🇸
Providence Medical Foundation, Fullerton, California, United States
🇺🇸Providence Saint John's Health Center - Saint John's Cancer Institute, Santa Monica, California, United States
Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease
- Conditions
- Alzheimer Dementia
- Interventions
- Drug: Human Mesenchymal Stem Cells and Lactated Riunger's SolutionOther: Placebo
- First Posted Date
- 2016-07-14
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Stemedica Cell Technologies, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02833792
- Locations
- 🇺🇸
John Wayne Cancer Institute @ Providence St. John's Health Center, Santa Monica, California, United States
Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging
- Conditions
- Dermatologic DisordersChronic Effect of Ultraviolet Radiation on Photoaged Skin
- Interventions
- Biological: Allogeneic Mesenchymal Bone Marrow Cells
- First Posted Date
- 2013-01-18
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- Stemedica Cell Technologies, Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT01771679
- Locations
- 🇺🇸
Naval Medical Center San Diego, San Diego, California, United States
🇺🇸eStudy Site, La Mesa, California, United States
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)
- Conditions
- ST Segment Elevation Myocardial Infarction (STEMI)Allogeneic Mesenchymal Bone Marrow Cells
- Interventions
- Biological: Stem cells
- First Posted Date
- 2013-01-18
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Stemedica Cell Technologies, Inc.
- Registration Number
- NCT01770613
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸Mercy Gilbert and Chandler Medical Center, Gilbert, Arizona, United States
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
- Conditions
- Ischemic Stroke
- Interventions
- Biological: Allogeneic adult mesenchymal bone marrow stem cells
- First Posted Date
- 2011-02-16
- Last Posted Date
- 2018-12-03
- Lead Sponsor
- Stemedica Cell Technologies, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT01297413
- Locations
- 🇺🇸
University of California Irvine Department of Neurology, Orange, California, United States
🇺🇸Mercy Gilbert and Chandler Medical Center, Gilbert, Arizona, United States
🇺🇸University of California San Diego Division of Neurological Surgery, San Diego, California, United States